No paralogue variants have been mapped to residue 364 for KCNQ1.
| KCNQ1 | VFAISFFALPAGILGSGFALKVQQKQRQKH>F<NRQIPA--AASLI-QTAWRCY---A-A-EN | 386 |
| KCNQ2 | LIGVSFFALPAGILGSGFALKVQEQHRQKH>F<EKRRNP--AAGLI-QSAWRFY---A-T-NL | 351 |
| KCNQ3 | LIGVSFFALPAGILGSGLALKVQEQHRQKH>F<EKRRKP--AAELI-QAAWRYY---A-T-NP | 390 |
| KCNQ4 | LLGISFFALPAGILGSGFALKVQEQHRQKH>F<EKRRMP--AANLI-QAAWRLY---S-T-DM | 357 |
| KCNQ5 | LLGISFFALPAGILGSGFALKVQEQHRQKH>F<EKRRNP--AANLI-QCVWRSY---A-A-DE | 385 |
| KCNA1 | IAGVLTIALPVPVIVSNFNYFYHRETEGEE>Q<AQLLH-----VS--SP-NLAS---D-S--- | 439 |
| KCNA10 | IAGVLTIALPVPVIVSNFNYFYHRETENEE>K<QNIPGEIERI-------------------- | 483 |
| KCNA2 | IAGVLTIALPVPVIVSNFNYFYHRETEGEE>Q<AQYLQ-----VT--SCPKIPS---S-P--- | 442 |
| KCNA3 | IAGVLTIALPVPVIVSNFNYFYHRETEGEE>Q<SQYMH-----VG--SCQHLSS-S-A-E--- | 513 |
| KCNA4 | IAGVLTIALPVPVIVSNFNYFYHRETENEE>Q<TQLTQ-----NAV-SCPYLPS-N-LLK--- | 595 |
| KCNA5 | IAGVLTIALPVPVIVSNFNYFYHRETDHEE>P<AVLKEE--QGTQS-QGPGLDR-G-V-Q-R- | 554 |
| KCNA6 | IAGVLTIALPVPVIVSNFNYFYHRETEQEE>Q<GQYTHV-------------TC-G------- | 483 |
| KCNA7 | IAGVLTISLPVPVIVSNFSYFYHRETEGEE>A<GMFSHV-------------DM-Q-P-C--- | 421 |
| KCNB1 | IAGVLVIALPIPIIVNNFSEFYKEQKRQEK>A<IKRREA--LERA--KRNG---SIVS-M-N- | 449 |
| KCNB2 | IAGVLVIALPIPIIVNNFSEFYKEQKRQEK>A<IKRREA--LERA--KRNG---SIVS-M-N- | 453 |
| KCNC1 | LAGVLTIAMPVPVIVNNFGMYYSLAMAKQK>L<PKKKKK--HIPR--PPQLGSP---N-YCK- | 473 |
| KCNC2 | LAGVLTIAMPVPVIVNNFGMYYSLAMAKQK>L<PRKRKK--HIPP--APQASSP---T-FCK- | 510 |
| KCNC3 | LAGVLTIAMPVPVIVNNFGMYYSLAMAKQK>L<PKKKNK--HIPR--PPQPGSP---N-YCK- | 576 |
| KCNC4 | LAGVLTIAMPVPVIVNNFGMYYSLAMAKQK>L<PKKRKK--HVPR--PAQLESP---M-YCK- | 509 |
| KCND1 | LSGVLVIALPVPVIVSNFSRIYHQNQRADK>R<RAQQKV--RLARIRLAKSGTT---N---A- | 445 |
| KCND2 | LSGVLVIALPVPVIVSNFSRIYHQNQRADK>R<RAQKKA--RLARIRAAKSGSA---N---A- | 443 |
| KCND3 | LSGVLVIALPVPVIVSNFSRIYHQNQRADK>R<RAQKKA--RLARIRVAKTGSS---N---A- | 440 |
| KCNF1 | LCGVIAIALPIHPIINNFVRYYNKQRVLET>A<AKHELE--LMEL--N------SSSG-G-E- | 439 |
| KCNG1 | LSGILLMAFPVTSIFHTFSRSYLELKQEQE>R<VMFRRA--QFLI----K-TKSQLSV----- | 494 |
| KCNG2 | LSGILLMAFPVTSIFHTFSRSYSELKEQQQ>R<AASPEP--ALQE----D-STHSATA----- | 439 |
| KCNG3 | VSGIVLLALPITFIYHSFVQCYHELKFRSA>R<YSR-----------------SLSTE----- | 433 |
| KCNG4 | LSGILIMAFPATSIFHTFSHSYLELKKEQE>Q<LQARLR--HLQN----T-GPASECE-LLD- | 491 |
| KCNS1 | LGGILVVALPITIIFNKFSHFYRRQKALEA>A<VRNSNH--QEFE--D------LLSS-I-D- | 490 |
| KCNS2 | LAGILVVVLPITLIFNKFSHFYRRQKQLES>A<MRSCDF--GDGM--K------EVPS-V-N- | 443 |
| KCNS3 | ICGILVVALPITIIFNKFSKYYQKQKDIDV>D<QCSEDA--PEKC--H------ELPY-F-N- | 439 |
| KCNV1 | LSGILVLALPIAIINDRFSACYFTLKLKEA>A<VRQREA--LKKL--TKNIATDSYIS-V-N- | 467 |
| KCNV2 | AFGIILNGMPISILYNKFSDYYSKLKAYEY>T<TIRRER--GEVN--F------MQRA-R-K- | 526 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.F364L | c.1090T>C | Putative Benign | SIFT: tolerated Polyphen: probably damaging |